Monday, April 19, 2021 11:10:40 AM
More content below
LFMD
-14.94%
LifeMD, Inc.
Mon, April 19, 2021, 7:30 AM
More content below
LFMD
-14.94%
Exceeds Initial Guidance Due to Stronger Than Expected March; 41% Growth Vs. Q4‘20
NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced expected record revenue of $18.2M for Q1’21. The Company had previously guided towards revenue to be greater than $17 million (Link). However, a stronger than expected March resulted in performance exceeding that guidance. The expected quarterly revenue represents an increase of 323% year-over-year and a 41% increase compared to last quarter. Telehealth order volume grew by 373% versus the year-ago quarter, driven by both strong retention and new patient acquisition.
Justin Schreiber, CEO of LifeMD commented, “We are pleased to report another strong quarter, as revenue for Q1‘21 grew by 323% compared to revenue in Q1’20 and more than 40% quarter-over-quarter, driven by a rapidly growing recurring subscriber base and efficient acquisition spending. We onboarded a substantial number of new patients to our platform this quarter at an improved cost per acquisition (“CPA”) when compared to the prior quarter. We are excited to share more detailed metrics on our upcoming earnings call.”
Subscriptions generated 92% of revenue in Q1’21, compared to 75% in Q1’20. The increase in subscription revenue is largely due to increased sales of the company’s Shapiro MD™ hair products for men and women under a new subscription-based program, as well as continued increased subscription sales of the company’s telemedicine brand for men, Rex MD™.
LifeMD CFO, Marc Benathen, commented, “LifeMD continues to realize the significant benefits of our subscription-based business model underscored by strong patient retention and growing levels of patient acquisition. Our team has done a tremendous job of thoroughly monitoring expenses across the full brand portfolio to ensure efficient spending, while achieving a 41% increase in sequential revenue growth. As mentioned, March 2021 was a record month. We look forward to providing a complete financial and operational update on our upcoming earnings call.”
Mr. Schreiber added, “I am very proud of what our management team has accomplished in short order, and with their help, LifeMD is well-positioned to continue achieving revenue growth and further expand its footprint nationwide. In bridging the gap between technology and healthcare, we are also driving innovation, as evidenced by our patients actively choosing to enroll in our subscription-based offerings. We were also able to expand our portfolio of brand offerings at the end of the quarter when we successfully launched NavaMD™, the Company’s teledermatology brand. We are pleased by the early data we are seeing from this newly launched brand. We are also gearing up for the launch of LifeMD’s longitudinal telehealth service as part of a holistic patient-centered business model and comprehensive brand portfolio.”
Recent LFMD News
- LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- LifeMD Appoints Dr. Calum MacRae to its Board of Directors • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- LifeMD to Report First Quarter 2024 Financial Results on May 8 • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- LifeMD to Participate in Upcoming Investor and Industry Conferences During May • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- LifeMD Reports Fourth Quarter 2023 Results • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher • IH Market News • 03/11/2024 10:39:47 AM
- LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Webinar • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- LifeMD Provides 2024 Financial Guidance • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service • Dow Jones News • 01/04/2024 09:30:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 12/26/2023 09:05:00 PM
- LifeMD and Medifast Partner to Offer Transformative Weight Management Solution • GlobeNewswire Inc. • 12/13/2023 11:00:00 AM
- LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium • GlobeNewswire Inc. • 12/07/2023 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™ • GlobeNewswire Inc. • 11/08/2023 01:00:00 PM
- LifeMD to Report Third Quarter 2023 Financial Results on November 8 • GlobeNewswire Inc. • 10/25/2023 12:00:00 PM
- Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy • GlobeNewswire Inc. • 10/03/2023 10:00:00 AM
- LifeMD to Participate in Two Investor Conferences in October • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM